Steroid pulse therapy impaired endothelial function while increasing plasma high molecule adiponectin concentration in patients with IgA nephropathy

Nephrology Dialysis Transplantation

Volumn 21, Issue 12, 2006, Pages 3475-3480

  Uchida, Haruhito Adam ^a   Nakamura, Yoshio ^a   Kaihara, Masanobu ^a   Norii, Hisanao ^a   Hanayama, Yoshihisa ^a   Sugiyama, Hitoshi ^a   Maeshima, Yohei ^a   Yamasaki, Yasushi ^a   Makino, Hirofumi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Asymmetric dimethylarginine; Endothelial dysfunction; Glucocorticoid; Hepatocyte growth factor; High molecular weight adiponectin; IgA nephropathy

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; IMMUNOGLOBULIN A; METHYLPREDNISOLONE; N(G),N(G) DIMETHYLARGININE; SCATTER FACTOR;

ADULT; ARTICLE; BLOOD VESSEL FUNCTION; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG PULSE THERAPY; DRUG RESPONSE; FEMALE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; MALE; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM; VASODILATATION;

ADIPONECTIN; ADULT; ENDOTHELIUM, VASCULAR; FEMALE; GLOMERULONEPHRITIS, IGA; GLUCOCORTICOIDS; HUMANS; MALE; METHYLPREDNISOLONE; PULSE THERAPY, DRUG;

EID: 33751406222     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl423     Document Type: Article

References (20)

1. Endemann DH, Schiffrin EL. Endothelial dysfunction. J Am Soc Nephrol 2004; 15: 1983-1992
2. Ghiadoni L, Cupisti A, Huang Y et al. Endothelial dysfunction and oxidative stress in chronic renal failure. J Nephrol 2004; 17: 512-519
3. Nelson CL, Karschimkus CS, Dragicevic G et al. Systemic and vascular inflammation is elevated in early IgA and type 1 diabetic nephropathies and relates to vascular disease risk factors and renal function. Nephrol Dial Transplant 2005; 20: 2420-2426
4. Ouchi N, Ohishi M, Kihara S et al. Association of hypoadiponectinemia with impaired vasoreactivity. Hypertension 2003; 42: 231-234
5. Corretti MC, Anderson TJ, Benjamin EJ et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002; 39: 257-265
6. Gokce N, Keaney JF,Jr., Hunter LM et al. Predictive value of noninvasively determined endothelial dysfunction for longterm cardiovascular events in patients with peripheral vascular disease. J Am Coll Cardiol 2003; 41: 1769-1775
7. Okamoto Y, Kihara S, Ouchi N et al. Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 2002; 106: 2767-2770
8. Kobayashi H, Ouchi N, Kihara S et al. Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ Res 2004; 94: E27-e3l
9. Hafezi-Moghadam A, Simoncini T, Yang Z et al. Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nat Med 2002; 8: 473-479
10. Iuchi T, Akaike M, Mitsui T et al. Glucocorticoid excess induces superoxide production in vascular endothelial cells and elicits vascular endothelial dysfunction. Circ Res 2003; 92: 81-87
11. Brotman DJ, Girod JP, Garcia MJ et al. Effects of short-term glucocorticoids on cardiovascular biomarkers. J Clin Endocrinol Metab 2005; 90: 3202-3208
12. Hotta O, Miyazaki M, Furuta T et al. Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy. Am J Kidney Dis 2001; 38: 736-743
13. Pozzi C, Andrulli S, Del Vecchio L et al. Corticosteroid effectiveness in IgA nephropathy: Long-term results of a randomized, controlled trial. J Am Soc Nephrol 2004; 15: 157-163
14. Stehouwer CD, Henry RM, Dekker JM, Nijpels G, Heine RJ, Bouter LM. Microalbuminuria is associated with impaired brachial artery, flow-mediated vasodilation in elderly individuals without and with diabetes: Further evidence for a link between microalbuminuria and endothelial dysfunction - the Hoorn Study. Kidney Int Suppl 2004; 92: S42-S44
15. Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R. Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun 2002; 290: 1084-1089
16. Halleux CM, Takahashi M, Delporte ML et al. Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue. Biochem Biophys Res Commun 2001; 288: 1102-1107
17. Fasshauer M, Kralisch S, Klier M et al. Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes. Biochem Biophys Res Commun 2003; 301: 1045-1050
18. Libe R, Morpurgo PS, Cappiello V et al. Ghrelin and adiponectin in patients with Cushing's disease before and after successful transsphenoidal surgery. Clin Endocrinol 2005; 62: 30-36
19. Xu A, Chan KW, Hoo RL et al. Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes. J Biol Chem 2005; 280: 18073-18080
20. Komai N, Ohishi M, Morishita R et al. Serum hepatocyte growth factor concentration is correlated with the forearm vasodilator response in hypertensive patients. Am J Hypertens 2002; 15: 499-506